Zheng, J., Yu, J., Yang, M., & Tang, L. (2019). Gefitinib suppresses cervical cancer progression by inhibiting cell cycle progression and epithelial-mesenchymal transition. Exp Ther Med.
Chicago ZitierstilZheng, Jianyun, Jianxin Yu, Min Yang, und Li Tang. "Gefitinib Suppresses Cervical Cancer Progression By Inhibiting Cell Cycle Progression and Epithelial-mesenchymal Transition." Exp Ther Med 2019.
MLA ZitierstilZheng, Jianyun, Jianxin Yu, Min Yang, und Li Tang. "Gefitinib Suppresses Cervical Cancer Progression By Inhibiting Cell Cycle Progression and Epithelial-mesenchymal Transition." Exp Ther Med 2019.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.